This Company Now Has the World's No. 1 Drug. Should You Invest $1,000?

Eli Lilly and rival drugmaker Novo Nordisk are the leading companies in the GLP-1 space, but others are emerging. Among them is Pfizer; in September that company announced it would acquire Metsera, a ...

Eli Lilly raises forecasts on surging international demand for weight-loss drugs

Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong overseas demand for weight-loss and ...

Trump administration nearing deal to cut prices on popular weight-loss drugs, reports say

The Trump administration is reportedly finalizing a deal with Eli Lilly and Novo Nordisk that would lower prices on Wegovy, ...

Eli Lilly says weight-loss pill a candidate for speedy approval under new US program

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
UPI

Celltrion vows to invest $1 billion to buy, upgrade U.S. Lilly plant

SEOUL, Sept. 23 (UPI) --South Korean biopharmaceutical company Celltrion said Tuesday it would invest at least $1 billion to take over a production facility from Eli Lilly in Branchburg, N.J., and ...
Investopedia

Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...